Busulfan and Fludarabine as Conditioning for Allogeneic Stem Cell Transplantation: a Pharmacokinetic Study

NCT00156858 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

200

Enrollment

OTHER

Sponsor class

Conditions

Hematologic Malignancy

Interventions

DRUG: intravenous busulfan

Sponsor

Alberta Health services